“Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287)”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 4, July 2025, p. s588, https://doi.org/10.25251/yvdyat28.